|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-5.44/0.83
|
企業價值
30.70M
|
資產負債 |
每股賬面淨值
0.32
|
現金流量 |
現金流量率
--
|
損益表 |
收益
0
|
每股收益
3.39
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/06/13 20:54 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
JanOne Inc is focused on being a clinical-stage pharmaceutical company committed to finding treatments for conditions that cause severe pain and bringing drugs to market with non-addictive pain-relieving properties. One of the Company's goals is to reduce the need for prescriptions for dangerous opioid drugs by treating underlying diseases that cause severe pain. The company operates in two operating segments, namely Biotechnology, and discontinued operations. |